Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2018 | Constellation Pharmaceuticals | Series F | 0 |
4/2015 | Veem | Seed Round | 0 |
3/2016 | Chronicled | Seed | 3.4M |
9/2014 | Anthology | Seed Round | 500k |
1/2014 | Plated | Series A | 5M |
8/2015 | Chronicled | Convertible Note | 1.4M |
4/2018 | PeerStreet | Series B | 29.5M |
8/2010 | Kroll Bond Rating Agency | Series A | - |
8/2010 | K2 Integrity | Series A | - |
3/2021 | Blockcap | Venture Round | 0 |
9/2016 | LoftSmart | Seed Round | 0 |
5/2021 | Genies | Series B | 65M |
7/2017 | LoftSmart | Seed Round | 2.7M |
2/2015 | Opendoor | Series B | 20M |
8/2013 | Kroll Bond Rating Agency | Series C | 15M |
7/2015 | Plated | Series B | 35M |
8/2014 | Plated | Series A | 0 |
1/2016 | Jetty | Seed Round | 4M |
12/2016 | Super | Series A | 6M |
12/2015 | Constellation Pharmaceuticals | Series E | 55M |
4/2019 | Super | Series B | 20M |
5/2018 | Alfred | Series B | 40M |
5/2015 | Paxos | Series A | 28.2M |
1/2015 | Reonomy | Series B | 13M |
6/2016 | Common Living | Series B | 16M |
10/2015 | Digital Currency Group | Seed Round | - |
7/2013 | NGM Biopharmaceuticals | Series C | 50M |
5/2021 | Genies | Series B | 0 |
3/2021 | Blockcap | Venture Round | 0 |
4/2019 | Super | Series B | 0 |
5/2018 | Alfred | Series B | 0 |
4/2018 | Constellation Pharmaceuticals | Series F | 0 |
4/2018 | PeerStreet | Series B | 0 |
7/2017 | LoftSmart | Seed Round | 0 |
12/2016 | Super | Series A | 0 |
9/2016 | LoftSmart | Seed Round | 0 |
6/2016 | Common Living | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|